AIR DNAse (alidornase alfa) / Protalix, SarcoMed - LARVOL DELTA

Oral inhalation for delivery of proteins and peptides to the lungs. (PubMed, Eur J Pharm Biopharm) - "While development of various biologics has been halted or has shown little effects, AIR DNase, alpha1-proteinase inhibitor, recombinant neuraminidase, and heparin are currently being evaluated in phase III trials. Several biologics are being tested for the treatment of coronavirus disease (COVID)-19, and it is expected that these trials will lead to improvements in pulmonary delivery of biologics."

Journal • Asthma • Immunology • Infectious Disease • Novel Coronavirus Disease • Pulmonary Disease • Respiratory Diseases

Protalix BioTherapeutics Reports 2018 Full Year Results and Provides Corporate Update (GlobeNewswire, Protalix BioTherapeutics, Inc.) - “In 2018, the Company received valuable feedback on PRX-110 from potential partners. While the data generated to date is very encouraging, further analysis will likely be required to maximize the potential value of this asset. Given the Company’s focused cash utilization, it does not plan to conduct further development of PRX-110 at this time.”

Clinical